Alexey Danilov, MD
Enriched profileProfessor, Division of Lymphoma, Department of Hematology & Hematopoietic Cell Transplantation; Co-Director, Toni Stephenson Lymphoma Center, City of Hope · City of Hope National Medical Center
Alexey Danilov is Professor, Division of Lymphoma, Department of Hematology & Hematopoietic Cell Transplantation; Co-Director, Toni Stephenson Lymphoma Center, City of Hope at City of Hope National Medical Center. OpenAlex indexes 632 publications with 7,234 citations (h-index 41); ClinicalTrials.gov lists 14 registered studies with this person as an investigator.
Data verified 14 Aug 2026
Overview
Updated 14 Oct 2026
Alexey Danilov, MD, is Professor, Division of Lymphoma, Department of Hematology & Hematopoietic Cell Transplantation at City of Hope National Medical Center, Duarte, CA. The public record shows 632 publications with 7,234 citations (h-index 41), centered on Hematology. It also documents an investigator role on 14 registered clinical trials, industry payments reported by 36 companies, 3 NIH-funded awards (2021–2026).
- Most recent indexed publication: 2026 · Research square
- Top research focus: Hematology
- 14 registered trials on ClinicalTrials.gov
- Open Payments reporting from 36 companies
Generated from the cited public record · current as of 14 Oct 2026. Every fact links its source below.
Indications focus
from trials led + research topicsResearch focus
OpenAlex concept fingerprintDrugs & molecules
across trials, industry payments and publicationsWorks with
trial sponsors and companies reporting paymentsScholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID; 28 in PubMed.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Clinical trials
Updated 14 Oct 2026
Listed as an investigator on 14 registered studies on ClinicalTrials.gov. The most recent:
- Zanubrutinib in Combination With Odronextamab for the Treatment of Patients With Richter's Transformation
Sponsor: City of Hope Medical Center
- Nemtabrutinib With Rituximab for the Treatment of Patients With Mantle Cell Lymphoma
Sponsor: City of Hope Medical Center
Industry payments
Updated 14 Oct 2026
36 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:
- Lilly USA, LLCProgram year20259 payments$20,104openpaymentsdata.cms.gov ↗
- AstraZeneca Pharmaceuticals LPProgram year202510 payments$15,494openpaymentsdata.cms.gov ↗
- ABBVIE INC.Program year202516 payments$12,217openpaymentsdata.cms.gov ↗
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cancer & immunology
77.3%Kinase inhibitor77.3%Brukinsa53%Calquence47%Part D<11 patientsDermatology
12.9%Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor12.9%Acyclovir100%Part D<11 patientsMusculoskeletal
9.8%Xanthine oxidase inhibitor9.8%Allopurinol100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
Updated 14 Oct 2026
3 NIH research awards on record, funded 2021–2026 per NIH RePORTER. The latest:
- Phase 1 and 2 Molecular and Clinical Pharmacodynamic Trials ETCTN
Beckman Research Institute/city of Hope
FY2026$1,915,725UM1CA186717 - Attacking the Tumor Cell-Immune Milieu Interface to Overcome Richter's Transformation
Columbia University Health Sciences
FY2026$607,354R01CA283171 - Attacking the Tumor Cell-Immune Milieu Interface to Overcome Richter's Transformation
Beckman Research Institute/city of Hope
FY2026$24,647R01CA283171
Publications
Updated 14 Oct 2026
Their five most recent publications, matched to their ORCID record and linked to PubMed.
Online presence
Updated 14 Oct 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Owned accounts
public accounts run by this person- ResearchGate
researchgate.net/scientific-contributions/Alexey-Danilov-2259981205
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →researchgate.net ↗ - Doximity
doximity.com/pub/alexey-danilov-md
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →doximity.com ↗ - LinkedIn
linkedin.com/in/alexey-danilov-753586b9
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →linkedin.com ↗
Mentions by others
where others cite or feature them- Facebook
facebook.com/OncLive/videos/alexey-danilov-md-phd-of-city-of-hope-discusses-frontline-treatment-selection-fo/759846973088769
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →facebook.com ↗ - Other
onclive.com/authors/alexey-danilov-md-phd-city-of-hope
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →onclive.com ↗ - LinkedIn
LinkedIn profile identifies him as Associate Director for Clinical Sciences, City of Hope (auth-walled; corroborated via SERP snippet only)
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →linkedin.com ↗
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Background & recognition
Updated 14 Oct 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Education
degrees and training on record- MD
PhD
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →ascopost.com ↗ - Fellowship
Hematology/Oncology, Tufts Medical Center, Boston, MA
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →binaytara.org ↗
Editorial & leadership roles
journal and society appointments- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →beckersoncology.com ↗
- Co-Director
Toni Stephenson Lymphoma Center, City of Hope
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →ascopost.com ↗ - Associate Director for Clinical Sciences
City of Hope Comprehensive Cancer Center
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →beckersoncology.com ↗ - provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →binaytara.org ↗
- Expert Faculty member
touchHAEMATOLOGY editorial board
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →touchhaematology.com ↗
Awards & honors
honors on the public record- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →bloodcancerunited.org ↗
Media & interviews
press, podcasts and appearances- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →vjhemonc.com ↗
- Author/contributor page
OncLive (City of Hope)
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →onclive.com ↗ - Author/contributor page
Blood Cancers Today
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →bloodcancerstoday.com ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
Sumanta Pal, MD
City of Hope National Medical Center
Joanne Mortimer, MD
City of Hope National Medical Center
Vinod Pullarkat, MD
City of Hope National Medical Center
Tanya Dorff, MD
City of Hope National Medical Center
Joseph Antin, MD
Boston University
Scott Kaufmann, MD
Mayo Clinic College of Medicine
Jeffrey Miller, MD
University of Minnesota Medical School
Ruben Mesa, MD
Atrium Health Wake Forest Baptist Comprehensive Cancer Center